Showing results (1-10 of 1,077) with videos related to
Sort By:
Pageof 108
Reviews in Medical Virology|December 6, 2024
Epigenetic Targeting for Controlling Persistent Neurotropic Infections Caused by Borna Virus and HIVYadi Li, Huating Luo, Hao Pang, et al.Journal of Cancer Research and Clinical Oncology|March 26, 2024
Risk of HBV reactivation in HCC patients undergoing combination therapy of PD-1 inhibitors and angiogenesis inhibitors in the antiviral eraRui Wang, Guili Tan, Dingjia Lei, et al.Polish Journal of Microbiology|June 21, 2024
Guanylate-Binding Protein 1 (GBP1) Enhances IFN-α Mediated Antiviral Activity against Hepatitis B Virus InfectionYadi Li, Haiying Luo, Xiaoxia Hu, et al.Frontiers in Medicine|April 18, 2022
Case Report: Chronic Active Epstein-Barr Virus Infection With Subcutaneous Nodules and Systemic DamageHuating Luo, Zhe Yuan, Bo QinJournal of Hepatocellular Carcinoma|October 2, 2023
Development and Validation of a Novel Prognosis Model Based on a Panel of Three Immunogenic Cell Death-Related Genes for Non-Cirrhotic Hepatocellular CarcinomaJiaojiao Gong, Renjie Yu, Xiaoxia Hu, et al.Infection and Drug Resistance|August 12, 2022
Disseminated Cryptococcal Infection of the Lumbar Spine in an Immunocompetent ManRui Wang, Huating Luo, Xiaojuan Xin, et al.Frontiers in Immunology|June 26, 2026
ENPP1 and IFIT2 in PBMCs as early predictive biomarkers for HBsAg clearance and responses to Peg-IFN-α in HBeAg-negative chronic hepatitis B patientsHao Pang, Xinglin Fu, Jinhong Jiang, et al.Frontiers in Pharmacology|July 13, 2026
Altered expression of MX2 and SAMD4A in PBMCs predicts early treatment responses in HBeAg-positive chronic hepatitis B patients during Peg-IFN-α therapyHao Pang, Qiqi Zhang, Lüping Chen, et al.BMC Gastroenterology|May 19, 2023
The expression of interleukin-1β in patients with chronic hepatitis B treated with pegylated-interferon-alpha combined with tenofovir disoproxil fumarate and monotherapyXiaoxia Hu, Haiying Luo, Guili Tan, et al.Frontiers in Immunology|February 2, 2026
Combined therapy with the estrogen receptor ERα and IFNα-2b suppresses HBV replication by inducing GBP1 expressionYadi Li, Jiaojiao Gong, Guili Tan, et al.Pageof 108